← Back to headlines
Medtronic's MiniMed Diabetes Business Seeks $784M in US IPO
Medtronic's diabetes business unit, MiniMed, is reportedly planning an Initial Public Offering (IPO) in the United States, aiming to raise $784 million.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
IMF Chief Warns Global Economy Faces Energy Shocks and Fiscal Pressures
16m ago
Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance
31m ago
TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe
35m ago
Montenegro Official Rejects Alleged Political Pressure Attempts
38m ago